Table 4.
Weighted mean (SE) of task-oriented behaviors of patients in sessions with pharmacists and pharmacy technicians
| Task-oriented communication | Question
|
Giving information
|
||
|---|---|---|---|---|
| Pharmacists’ sessions | Technicians’ sessions | Pharmacists’ sessions | Technicians’ sessions | |
| Medicala | 0.33 (0.07)* | 0.12 (0.07)* | 22.94 (2.20)* | 17.01 (2.24)* |
| Prevalence | 0.01 (0.01) | 0.00 (0.01) | 0 | 0 |
| Prognosis | 0 | 0 | 0 | 0 |
| Exacerbations | 0 | 0 | 0.21 (0.10) | 0.15 (0.10) |
| Current health status | 0.06 (0.03) | 0.06 (0.03) | 5.52 (0.53) | 4.31 (0.53) |
| Medical history | 0.03 (0.02) | 0.01 (0.02) | 5.01 (0.66)** | 2.24 (0.68)** |
| Heredity | 0 | 0 | 0.11 (0.12) | 0.30 (0.12) |
| Contact other health care providers about asthma/COPD | 0.02 (0.01) | 0.01 (0.01) | 2.83 (0.41) | 2.46 (0.42) |
| Lung function test | 0.08 (0.06) | 0.02 (0.06) | 1.86 (0.35) | 0.99 (0.36) |
| Explanation about asthma/COPD | 0.07 (0.03) | 0.00 (0.03) | 0.15 (0.05) | 0.06 (0.05) |
| Medical, other | 0.06 (0.02) | 0.02 (0.02) | 7.33 (1.47) | 6.62 (1.49) |
| Therapeutic: ICS treatmenta | 2.62 (0.35) | 2.28 (0.36) | 44.19 (3.08) | 40.72 (3.10) |
| Reason for use/need | 0.06 (0.05) | 0.07 (0.05) | 1.19 (0.18) | 1.00 (0.18) |
| Dosage | 0.36 (0.10)* | 0.08 (0.10)* | 5.67 (0.49)*** | 3.92 (0.49)*** |
| Adherence | 0.04 (0.02) | 0.01 (0.02) | 1.95 (0.31) | 1.43 (0.31) |
| Medicinal effects | 0.15 (0.04) | 0.05 (0.04) | 2.44 (0.38) | 1.82 (0.39) |
| Side-effects | 0.24 (0.08) | 0.23 (0.08) | 3.86 (0.57) | 3.91 (0.58) |
| Inhaler/inhalation | 1.52 (0.26) | 1.64 (0.26) | 22.76 (2.11) | 22.64 (2.12) |
| Contact other health care providers about ICS | 0.08 (0.02) | 0.02 (0.02) | 1.62 (0.30) | 2.11 (0.30) |
| Self-management | 0 | 0 | 0.16 (0.09) | 0.29 (0.09) |
| Facilitators | 0.01 (0.01) | 0.01 (0.01) | 0.51 (0.15) | 0.56 (0.15) |
| Barriers | 0.02 (0.02) | 0.02 (0.02) | 0.92 (0.19)* | 0.34 (0.19)* |
| ICS, other | 0.14 (0.04) | 0.13 (0.04) | 2.81 (0.29) | 2.47 (0.29) |
| Therapeutic: Non-ICS treatmenta | 0.74 (0.15) | 0.59 (0.15) | 15.21 (1.49) | 12.40 (1.52) |
| Lifestyle/sociala | 0.17 (0.05)** | 0.00 (0.05)** | 9.29 (1.43)* | 5.74 (1.45)* |
| Smoking | 0 | 0 | 0.99 (0.31) | 0.62 (0.31) |
| Exercise | 0.05 (0.02) | 0.00 (0.02) | 1.99 (0.34)* | 1.01 (0.35)* |
| Weight | 0 | 0 | 0.00 (0.09) | 0.18 (0.09) |
| Nutrition | 0 | 0 | 0.30 (0.19) | 0.33 (0.19) |
| Stress | 0 | 0 | 0.01 (0.03) | 0.04 (0.03) |
| Drugs | 0 | 0 | 0.16 (0.08) | 0.00 (0.08) |
| Influenza vaccine | 0 | 0 | 0.04 (0.06) | 0.18 (0.06) |
| (Living) environment | 0.07 (0.04) | 0.00 (0.04) | 1.52 (0.25)** | 0.70 (0.25)** |
| Social context | 0.05 (0.02)* | 0.00 (0.02)* | 2.75 (0.67) | 1.60 (0.68) |
| Lifestyle, other | 0.01 (0.01) | 0.00 (0.01) | 1.43 (0.37) | 0.96 (0.37) |
| Psychosocial/feelingsa | 0.09 (0.04) | 0.05 (0.04) | 5.84 (0.78) | 5.37 (0.79) |
| ICS concerns | 0.05 (0.02) | 0.02 (0.02) | 0.98 (0.21)* | 0.45 (0.21)* |
| ICS necessities | 0.02 (0.01) | 0.00 (0.01) | 0.51 (0.13) | 0.44 (0.13) |
| Psychosocial ICS, other | 0.02 (0.01) | 0.01 (0.01) | 2.14 (0.37) | 2.05 (0.37) |
| Non-ICS | 0.00 (0.01) | 0.01 (0.01) | 2.15 (0.55) | 2.39 (0.56) |
| Other | 0.44 (0.09) | 0.21 (0.09) | 17.92 (1.31)** | 11.89 (1.34)** |
| Totala | 4.38 (0.49) | 3.22 (0.50) | 115.40 (6.28)*** | 92.77 (6.36)*** |
Notes:
a
Totals have been calculated in the model and can be different from the total of individual categories.
*
Significant at P<0.05.
**
Significant at P<0.01.
***
Significant at P<0.001.
Abbreviations: SE, standard error; COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids.